Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes

NCT01973231 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

404

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: liraglutide
DRUG: lixisenatide

Sponsor

Novo Nordisk A/S